0001209191-20-019804.txt : 20200317
0001209191-20-019804.hdr.sgml : 20200317
20200317193354
ACCESSION NUMBER: 0001209191-20-019804
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200315
FILED AS OF DATE: 20200317
DATE AS OF CHANGE: 20200317
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Warren Brian
CENTRAL INDEX KEY: 0001653309
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-34877
FILM NUMBER: 20722689
MAIL ADDRESS:
STREET 1: C/O CORESITE REALTY CORPORATION
STREET 2: 1001 17TH STREET, SUITE 500
CITY: DENVER
STATE: CO
ZIP: 80202
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CoreSite Realty Corp
CENTRAL INDEX KEY: 0001490892
STANDARD INDUSTRIAL CLASSIFICATION: REAL ESTATE INVESTMENT TRUSTS [6798]
IRS NUMBER: 000000000
STATE OF INCORPORATION: MD
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1001 17TH STREET
STREET 2: SUITE 500
CITY: DENVER
STATE: CO
ZIP: 80202
BUSINESS PHONE: (866) 777-2673
MAIL ADDRESS:
STREET 1: 1001 17TH STREET
STREET 2: SUITE 500
CITY: DENVER
STATE: CO
ZIP: 80202
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-03-15
0
0001490892
CoreSite Realty Corp
COR
0001653309
Warren Brian
C/O CORESITE REALTY CORPORATION
1001 17TH STREET, SUITE 500
DENVER
CO
80202
0
1
0
0
SVP, Engineering & Product
Common Stock
2020-03-15
4
A
0
3805
0.00
A
23867
D
Common Stock
2020-03-15
4
A
0
4440
0.00
A
28307
D
Common Stock
2020-03-16
4
S
0
200
94.14
D
28107
D
Common Stock
2020-03-16
4
S
0
200
96.04
D
27907
D
Common Stock
2020-03-16
4
S
0
200
98.00
D
27707
D
Common Stock
2020-03-16
4
S
0
100
99.29
D
27607
D
Common Stock
2020-03-16
4
S
0
223
101.46
D
27384
D
Common Stock
2020-03-16
4
S
0
300
102.92
D
27084
D
Common Stock
2020-03-17
4
S
0
1000
102.79
D
26084
D
Represents restricted stock granted under the issuer's 2010 Equity Incentive Award Plan (the "2010 Plan"). The restricted stock vests in three equal annual installments beginning on March 15, 2021, provided that the reporting person remains in continuous service with the issuer as of each vesting date.
Represents performance-based restricted shares ("PSAs") granted under the 2010 Plan. The number of PSAs earned is based on the issuer's achievement of relative total shareholder return ("TSR") measured versus the MSCI US REIT Index over a three-year performance period ending December 31, 2022, and the number of shares earned may range from 25% to 175%. The PSAs are earned as follows: (i) 20% of the PSAs are earned upon TSR achievement in year one of the performance period, (ii) 20% of the PSAs are earned upon TSR achievement in year two of the performance period, (iii) 20% of the PSAs are earned upon TSR achievement in year three of the performance period, and (iv) 40% of the PSAs are earned upon a cumulative TSR achievement over the three-year performance period, subject to the reporting person's continued service with the issuer at the end of the three-year performance period. The PSAs are granted and issued at 175% of the target amount.
The shares were sold pursuant to a sales plan adopted by the reporting person and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934.
Represents shares sold by the reporting person to cover tax obligations upon the vesting of restricted stock.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $95.95 to $96.13, inclusive. The reporting person undertakes to provide to the issuer, any shareholder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes 5 through 8.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $97.66 to $98.33, inclusive.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $100.97 to $101.90, inclusive.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $102.54 to $103.32, inclusive.
/s/ Derek S. McCandless, Attorney-in-Fact
2020-03-17